Shopping Cart 0
Cart Subtotal
USD 0

Japan Metered Dose Inhaler Devices Market Outlook to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4995

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 9990

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 14985
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Japan Metered Dose Inhaler Devices Market Outlook to 2023

Summary

GlobalData's new report, "Japan Metered Dose Inhaler Devices Market Outlook to 2023", provides key market data on the Japan Metered Dose Inhaler Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) for Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Metered Dose Inhaler Devices.

Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.

2016 company shares and distribution shares data for each of the market segments.

Global corporate-level profiles of key companies operating within the Japan Metered Dose Inhaler Devices market.

Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc and Boehringer Ingelheim GmbH.

Reasons to buy

Develop business strategies by identifying the key market segments poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 3

2 Introduction 4

2.1 What Is This Report About? 4

2.2 Metered Dose Inhaler Devices Market Segmentation 4

2.3 Definitions of Markets Covered in the Report 4

3 Metered Dose Inhaler Devices Market, Japan 5

3.1 Metered Dose Inhaler Devices Market, Japan, Revenue ($m), 2009-2016 5

3.2 Metered Dose Inhaler Devices Market, Japan, Revenue ($m), 2016-2023 6

3.3 Metered Dose Inhaler Devices Market, Japan, Volume (Units), 2009-2016 7

3.4 Metered Dose Inhaler Devices Market, Japan, Volume (Units), 2016-2023 8

3.5 Metered Dose Inhaler Devices Market, Japan, Average Price ($), 2009-2023 9

3.6 Metered Dose Inhaler Devices Market, Japan, Distribution Share by Revenue ($m), 2015-2016 10

3.7 Metered Dose Inhaler Devices Market, Japan, Company Share by Revenue ($m), 2016 11

4 Overview of Key Companies in Japan, Metered Dose Inhaler Devices Market 13

4.1 GlaxoSmithKline Plc 13

4.1.1 Company Overview 13

4.2 AstraZeneca Plc 13

4.2.1 Company Overview 13

4.3 Boehringer Ingelheim GmbH 13

4.3.1 Company Overview 13

4.4 Pfizer Inc 14

4.4.1 Company Overview 14

4.5 Merck & Co Inc 14

4.5.1 Company Overview 14

5 Recent Developments 15

5.1 Other Significant Developments 15

5.1.1 Jan 26, 2017: Achievement of sales milestone for COPD products 15

6 Appendix 16

6.1 Research Methodology 17

6.1.1 Coverage 17

6.1.2 Secondary Research 17

6.1.3 Primary Research 18

6.1.4 Company Share Analysis 18

6.1.5 Distribution Share Analysis 18

6.1.6 Benchmarking 19

6.2 GlobalData Consulting 19

6.3 Contact Us 20

6.4 Disclaimer 20


List Of Figure

1.2 List of Figures

Figure 1: Metered Dose Inhaler Devices Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 5

Figure 2: Metered Dose Inhaler Devices Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 6

Figure 3: Metered Dose Inhaler Devices Market, Japan, Volume (Units), Historic, 2009-2016 7

Figure 4: Metered Dose Inhaler Devices Market, Japan, Volume (Units), Forecast, 2016-2023 8

Figure 5: Metered Dose Inhaler Devices Market, Japan, Company Share (%) 2016 11


List Of Table

1.1 List of Tables

Table 1: Metered Dose Inhaler Devices Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 5

Table 2: Metered Dose Inhaler Devices Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 6

Table 3: Metered Dose Inhaler Devices Market, Japan, Volume (Units), Historic, 2009-2016 7

Table 4: Metered Dose Inhaler Devices Market, Japan, Volume (Units), Forecast, 2016-2023 8

Table 5: Metered Dose Inhaler Devices Market, Japan, Average Price ($), Historic, 2009-2016 9

Table 6: Metered Dose Inhaler Devices Market, Japan, Average Price ($), Forecast, 2016-2023 9

Table 7: Metered Dose Inhaler Devices Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2015-2016 10

Table 8: Metered Dose Inhaler Devices Market, Japan, Company Share by Revenue ($m), USD Constant, 2016 12

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Drug Delivery Devices, Central Venous Catheters, Needle Free Injections, Infusion Systems, Metered Dose Inhaler Devices, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, GlaxoSmithKline Plc, AstraZeneca Plc, Boehringer Ingelheim GmbH, Pfizer Inc, Merck & Co Inc, Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, INJEX-Equidyne Systems, Bioject Medical Technologies Inc , Antares Pharma Inc, PharmaJet Inc, MK Global Co., The European Pharma Group, Hospira Inc, Becton Dickinson and Co, Baxter International Inc, Fresenius Kabi AG, Medtronic plc, B. Braun Melsungen AG, Terumo Corp, Smiths Medical, Nipro Corp, JMS Co Ltd


Companies

GlaxoSmithKline Plc

AstraZeneca Plc

Boehringer Ingelheim GmbH

Pfizer Inc

Merck & Co Inc